[Hepatitic complications and transfusional support in the remission-induction treatment of acute myeloid leukemia. Clinical study of l22 cases].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001219:Aspartate Aminotransferases / Q000097:blood; D001803:Blood Transfusion; D002648:Child; D004796:Clinical Enzyme Tests; D005260:Female; D006505:Hepatitis / Q000175:diagnosis / Q000453:epidemiology* / Q000276:immunology; D006509:Hepatitis B / Q000453:epidemiology / Q000276:immunology; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000150:complications / Q000188:drug therapy / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011379:Prognosis
D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase
Complicanza epatitica e supporto trasfusionale nel trattamento di induzione della leucemia acuta mieloide. Studio clinico di 122 casi.